Clinical Trials · NCT04790708
Peptide Receptor Radionuclide Therapy (PRRT) in Tumors With High Expression of Somatostatin Receptors (Phase 2)
- Phase
- N/A
- Recruitment status
- Unknown
- Sponsor
- University Hospital of Ferrara
- Enrollment
- 250
- Start date
- Jul 2018
- Locations
- 1 site, Italy
- Primary endpoint
- Disease Control Rate